D
SELLAS Life Sciences Group, Inc. SLS
$1.92 $0.0955.22% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 11.63% 39.23% 17.20% 23.30% 15.50%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 37.71% 6.19% -16.64% -22.11% -29.55%
Change in Net Operating Assets 48.62% -116.09% -134.88% -171.11% -544.37%
Cash from Operations 24.29% 15.71% -48.25% -13.26% -27.97%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 921.74% -11.50% -97.89% 36,362.96% --
Repurchase of Common Stock -- -- -106.45% -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 921.74% -11.50% -99.76% 36,362.96% 1,527.59%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 66.55% -8.65% -396.53% 220.80% 8.19%